Xenon Pharmaceuticals Inc. Contracts & Agreements

87 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
[] Shares Xenon Pharmaceuticals Inc. UNDERWRITING AGREEMENT
Underwriting Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2014
Amended and Restated 2014 Equity Incentive Plan and form of share option agreement used thereunder
Bonus & Incentive Agreements
Xenon Pharmaceuticals Inc.
2024
Form of Performance Share Award Agreement
Bonus & Incentive Agreements
Xenon Pharmaceuticals Inc.
2024
Description of Securities
Xenon Pharmaceuticals Inc.
2024
Consent to Alterations Agreement between Redstone Enterprises Ltd. and Xenon Pharmaceuticals Inc., effective August 16, 2023
Xenon Pharmaceuticals Inc.
2024
Employment Agreement, dated December 15, 2023, by and between the Company and James Empfield
Employment Agreements
Xenon Pharmaceuticals Inc.
2024
Underwriting Agreement, dated November 29, 2023, among Xenon Pharmaceuticals Inc., J.P. Morgan Securities LLC, Jefferies LLC, BofA Securities, Inc., Stifel, Nicolaus & Company,...
Underwriting Agreements
Xenon Pharmaceuticals Inc.
2023
Form of Pre-Funded Warrant
Warrant Agreements
Xenon Pharmaceuticals Inc.
2023
Consent to Alterations Agreement between Redstone Enterprises Ltd. and Xenon Pharmaceuticals Inc., effective March 27, 2023
Xenon Pharmaceuticals Inc.
2023
Employment Agreement, dated November 7, 2022, by and between the Company and Andrea DiFabio
Employment Agreements
Xenon Pharmaceuticals Inc.
2022
Consent to Alterations and Lease Modification Agreement between Redstone Enterprises Ltd. and Xenon Pharmaceuticals Inc., effective May 19, 2022
Lease Agreements
Xenon Pharmaceuticals Inc.
2022
Underwriting Agreement, dated June 22, 2022, among Xenon Pharmaceuticals Inc., Jefferies LLC, J.P. Morgan Securities LLC, SVB Securities LLC and Stifel, Nicolaus & Company,...
Underwriting Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2022
Form of Pre-Funded Warrant
Warrant Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2022
Amended and Restated 2014 Equity Incentive Plan and form of share option agreement used thereunder
Bonus & Incentive Agreements
Xenon Pharmaceuticals Inc.
2022
Amendment #2, dated February 25, 2022, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc
Collaboration Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2022
Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement, dated March 1, 2022, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company,...
Sales Agreements
Xenon Pharmaceuticals Inc.
2022
Share Purchase Agreement, dated as of January 11, 2022, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc
Share Agreements
Xenon Pharmaceuticals Inc.
2022
Lease Agreement, dated as of November 24, 2021, by and between the Company and Redstone Enterprises Ltd
Lease Agreements
Xenon Pharmaceuticals Inc.
2021
Employment Agreement, dated August 18, 2021, by and between the Company and Christopher Kenney
Employment Agreements
Xenon Pharmaceuticals Inc.
2021
Underwriting Agreement, dated October 5, 2021, among Xenon Pharmaceuticals Inc., Jefferies LLC, SVB Leerink LLC, and Stifel, Nicolaus & Company, Incorporated, as representatives...
Underwriting Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2021
Form of Pre-Funded Warrant
Warrant Agreements
Xenon Pharmaceuticals Inc.
2021
Share Purchase Agreement, dated as of September 8, 2021, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc
Share Agreements
Xenon Pharmaceuticals Inc.
2021
Termination Agreement, dated August 6, 2021, by and among Xenon Pharmaceuticals Inc., Genentech, Inc. and F. Hoffmann-La Roche Ltd
Termination Agreements
Xenon Pharmaceuticals Inc.
2021
Underwriting Agreement, dated March 9, 2021, among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several...
Underwriting Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2021
Form of Pre-Funded Warrant
Warrant Agreements
Xenon Pharmaceuticals Inc.
2021
Form of Share Option Agreement, as amended, under the Amended and Restated 2014 Equity Incentive Plan
Bonus & Incentive Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2021
Lease Modification Agreement, effective October 5, 2020, by and between the Company and Redstone Enterprises Ltd
Lease Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2021
Amendment #1, dated January 13, 2021, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc
Collaboration Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2021
Employment Agreement, dated January 13, 2021, by and between the Company and Ian Mortimer
Employment Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2021
Employment Agreement, dated January 13, 2021, by and between the Company and Simon Pimstone
Employment Agreements
Xenon Pharmaceuticals Inc.
2021
Employment Agreement, dated January 13, 2021, by and between the Company and Sherry Aulin
Employment Agreements
Xenon Pharmaceuticals Inc.
2021
Employment Agreement, dated July 17, 2020, by and between the Company and Christopher Von Seggern
Employment Agreements
Xenon Pharmaceuticals Inc.
2020
Amendment to Asset Purchase Agreement, dated August 4, 2020, by and between the Company and 1st Order Pharmaceuticals, Inc
Purchase Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2020
At-the-Market Equity Offering Sales Agreement dated as of August 6, 2020, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Xenon Pharmaceuticals Inc.
2020
Amended and Restated 2014 Equity Incentive Plan and form of share option agreement used thereunder
Bonus & Incentive Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2020
Description of Securities
Xenon Pharmaceuticals Inc.
Biotechnology
2020
Amended and Restated Employment Agreement, dated March 19, 2019, by and between the Company and Robin Sherrington
Employment Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2020
Amended and Restated Employment Agreement, dated March 20, 2019, by and between the Company and James Empfield
Employment Agreements
Xenon Pharmaceuticals Inc.
2020
Underwriting Agreement, dated January 22, 2020, among Xenon Pharmaceuticals Inc., Jefferies LLC, Stifel, Nicolaus & Company, Incorporated, and Guggenheim Securities, LLC as...
Underwriting Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2020
At-the-Market Equity Offering Sales Agreement dated as of November 5, 2019, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Xenon Pharmaceuticals Inc.
2019
2019 Inducement Equity Incentive Plan and related form of share option agreement
Bonus & Incentive Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2019
Amended and Restated Employment Agreement, dated March 19, 2019, by and between the Company and Simon Pimstone
Employment Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2019
Amended and Restated Employment Agreement, dated March 19, 2019, by and between the Company and Ian Mortimer
Employment Agreements
Xenon Pharmaceuticals Inc.
2019
Amended and Restated Employment Agreement, dated March 19, 2019, by and between the Company and Ernesto Aycardi
Employment Agreements
Xenon Pharmaceuticals Inc.
2019
Form of Offer of Employment (CDN Executive)
Employment Agreements
Xenon Pharmaceuticals Inc.
2019
Form of Amended and Restated Employment Agreement (CDN Executive)
Employment Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2019
Form of Offer of Employment (U.S. Executive)
Employment Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
MA
2019
Form of Amended and Restated Employment Agreement (U.S. Executive)
Employment Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
MA
2019
Amended and Restated Amendment #7, dated September 27, 2018, to the Collaborative Research and License Agreement, dated December 22, 2011, by and among the Company, Genentech,...
License Agreements
Xenon Pharmaceuticals Inc.
2018
Underwriting Agreement, dated September 12, 2018, among Xenon Pharmaceuticals, Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several...
Underwriting Agreements
Xenon Pharmaceuticals Inc.
2018
Milestone and Royalty Buy-Out Agreement, dated September 7, 2018, by and among Xenon Pharmaceuticals Inc., Valeant Pharmaceuticals Ireland Limited and Valeant Pharmaceuticals...
Xenon Pharmaceuticals Inc.
Biotechnology
DE
2018
Letter Amendment #7, dated July 25, 2018, to the Collaborative Research and License Agreement, dated December 22, 2011, by and among the Company, Genentech, Inc. and F....
License Agreements
Xenon Pharmaceuticals Inc.
2018
Warrant to Purchase Shares, dated August 3, 2018, by and between Xenon Pharmaceuticals Inc. and Silicon Valley Bank
Warrant Agreements
Xenon Pharmaceuticals Inc.
2018
Amended and Restated Loan and Security Agreement, dated August 3, 2018, by and among Xenon Pharmaceuticals Inc., Xenon Pharmaceuticals USA Inc. and Silicon Valley Bank
Loan Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
CA
2018
At-the-Market Equity Offering Sales Agreement, dated as of July 11, 2018, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2018
First Loan Modification to Loan and Security Agreement, dated June 12, 2018, by and among Xenon Pharmaceuticals Inc., Xenon Pharmaceuticals USA Inc. and Silicon Valley Bank
Loan Agreements
Xenon Pharmaceuticals Inc.
2018
At-the-Market Equity Offering Sales Agreement, dated as of May 8, 2018, between Xenon Pharmaceuticals Inc. and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2018
Specimen Series 1 Preferred Share Certificate
Share Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2018
Exchange Agreement, dated March 23, 2018, by and among the Company and the shareholders listed in Schedule B thereto
Exchange Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2018
Termination Agreement by and among Xenon Pharmaceuticals Inc., Teva Pharmaceuticals International GmbH and Teva Canada Limited dated March 7, 2018
Termination Agreements
Xenon Pharmaceuticals Inc.
2018
Warrant to Purchase Shares, dated December 18, 2017, by and between Xenon Pharmaceuticals Inc. and Silicon Valley Bank
Warrant Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2017
Loan and Security Agreement, dated December 18, 2017, by and among Xenon Pharmaceuticals Inc., Xenon Pharmaceuticals USA Inc. and Silicon Valley Bank
Loan Agreements
Xenon Pharmaceuticals Inc.
2017
APPENDIX A ADDITIONAL TERMS TO EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
MA
2017
SHARE OPTION AGREEMENT
Share Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2017
4,000,000 Shares XenonPharmaceuticals Inc. UNDERWRITING AGREEMENT
Underwriting Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
NY
2016
LEASE MODIFICATION AGREEMENT
Lease Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2016
Appendix A Xenon Pharmaceuticals Inc., & Genentech, Inc., Research Plan November 9, 2015
Xenon Pharmaceuticals Inc.
Biotechnology
2016
LEASE MODIFICATION AGREEMENT
Lease Agreements
Xenon Pharmaceuticals Inc.
2015
ScheduleA-1 NaV1.6
Xenon Pharmaceuticals Inc.
Biotechnology
2015
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2014
EXCLUSIVE COLLABORATIVE RESEARCH AND OPTION AGREEMENT by and between MERCKSHARP & DOHME RESEARCH LTD. and XENON PHARMACEUTICALS INC.
Xenon Pharmaceuticals Inc.
2014
SUBLICENSE AND RESEARCH AGREEMENT
Xenon Pharmaceuticals Inc.
2014
XENON PHARMACEUTICALS INC. and GENENTECH, INC. and F.HOFFMANN-LA ROCHE LTD COLLABORATIVE RESEARCH AND LICENSE AGREEMENT DECEMBER 22, 2011
License Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
CA
2014
XENON PHARMACEUTICALS INC. and IVAX INTERNATIONAL GMBH COLLABORATIVE DEVELOPMENT AND LICENSE AGREEMENT Effective as of December 7, 2012
License Agreements
Xenon Pharmaceuticals Inc.
2014
LICENSE AGREEMENT
License Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2014
XENON PHARMACEUTICALS INC. AMENDED AND RESTATED STOCK OPTION PLAN
Stock Agreements
Xenon Pharmaceuticals Inc.
2014
SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments
Xenon Pharmaceuticals Inc.
2014
SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments
Xenon Pharmaceuticals Inc.
Biotechnology
2014
SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments
Xenon Pharmaceuticals Inc.
Biotechnology
2014
SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments
Xenon Pharmaceuticals Inc.
2014
SCHEDULE A Disclosure of Volunteer, Board and Other External Commitments
Xenon Pharmaceuticals Inc.
2014
INDEMNIFICATION AGREEMENT BETWEEN XENONPHARMACEUTICALS INC. AND MADE AS OF , 2014 INDEMNIFICATION AGREEMENT,
Indemnification Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2014
Consulting Agreement
Consulting Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2014
XENON PHARMACEUTICALS INC. AMENDED AND RESTATED STOCK OPTION PLAN
Stock Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2014
2014 EQUITY INCENTIVE PLAN XENON PHARMACEUTICALS INC. ARTICLE 1 PURPOSE
Bonus & Incentive Agreements
Xenon Pharmaceuticals Inc.
2014
TABLE OF CONTENTS
Xenon Pharmaceuticals Inc.
2014
XENON PHARMACEUTICALS INC. COMMON SHARE PUT AGREEMENT March 19, 2014 XENON PHARMACEUTICALS INC. COMMON SHARE PUT AGREEMENT
Share Agreements
Xenon Pharmaceuticals Inc.
Biotechnology
2014